🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label, multicenter, prospective study to compare...
Status
Completed
Location
St. Francis Hosptial and Medical Center
Start Date
2008-05-01
Trial ID
NCT00722137
The ImbruVeRCHOP-Trials is an Investigator-initiated, single-arm, multi-cen...
Status
Completed
Location
Charité - Universitätsmedizin Berlin, Hematology, Oncology and Tumor Immunology, Campus Virchow Klinikum
Start Date
2017-03-17
Trial ID
NCT03129828
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Alaska Regional Hospital Cancer Center
Start Date
2006-08
Trial ID
NCT00376961
Treatments Being Tested
Diffuse large B cell lymphoma (DLBCL) is the most common non-Hodgkin's lymp...
Status
Completed
Location
Hospital Clínico Universitario Lozano Blesa
Start Date
2013-10-03
Trial ID
NCT01848132
Treatments Being Tested
This is an open-label (doctors and patients know which drug will be given),...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2008-02
Trial ID
NCT00634179
Treatments Being Tested
The main purpose of this study is to begin to collect information and try t...
Status
Terminated
Location
Dana Farber Cancer Institute
Start Date
2006-07
Trial ID
NCT00361621
Treatments Being Tested
The aims of this study are: * To evaluate the benefits of the addition of ...
Status
Completed
Location
Kantonsspital Aarau
Start Date
2011-04
Trial ID
NCT01324596
Treatments Being Tested
This is a randomized, open-label, active-control, parallel-group, multicent...
Status
Completed
Location
Universitair Ziekenhuis Gent - UZ GENT, Hematologie, 9K12IE 9de verdiep- polikliniek Hematologie
Start Date
2010-01
Trial ID
NCT01040871
Treatments Being Tested
The primary objective of this study is to evaluate the response rate and to...
Status
Completed
Location
Hôpital Saint-Louis
Start Date
2005-01
Trial ID
NCT00169468
Treatments Being Tested
Primary Objective: To determine the toxicity profile and maximum tolerated...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2004-01
Trial ID
NCT00151320
Treatments Being Tested